Summary:
This study will assess the safety and efficacy of ARQ-151 cream applied once a day for 24 weeks by subjects with chronic plaque psoriasis
This is an open-label study in which ARQ-151 cream is applied once daily x 24 weeks to subjects with psoriasis
Inclusion Criteria:
- Participants legally competent to sign and give informed consent
- Males and females ages 2 years and older (inclusive)
Qualified Participants May Receive:
- Compensation for participation
- Travel expenses covered
- Treatment at no cost to you